# Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section

> **NCT02739815** · PHASE4 · COMPLETED · sponsor: **Talkha Central Hospital** · enrollment: 200 (actual)

## Conditions studied

- Hemorrhage of Cesarean Section and/or Perineal Wound
- Postpartum Hemorrhage

## Interventions

- **DRUG:** Normal Saline containing a prophylactic Antibiotic 1 g
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02739815
- **Lead sponsor:** Talkha Central Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739815, "Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02739815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*